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Ab s t r a c t
Background: Gradual impairment of exercise tolerance is the commonest sign of heart failure (HF). Little is known as to
which cardiac contributors of poor exercise capacity carry an independent prognostic information in HF.
Aim: We investigated the prognostic role of exercise echocardiography (ex-echo) in HF patients.
Methods: We studied 85 consecutive, symptomatic HF patients (66 males, mean age 62.5 ± 11.8 [range 21–83] years,
mean left ventricular ejection fraction [LVEF] 27.2 ± 9.5%). The end-point was all-cause mortality. During the follow-up
period (mean 43 ± 21 months) 21 patients died. Resting echocardiography and ex-echo, with the simultaneous measure-
ment of peak oxygen uptake (VO2peak), was performed in each patient using a semi-supine ergometer (20 W, 2-min incre-
ments). Apart from conventional assessment of systolic and diastolic function (EF, E/A, DT, IVRT) or right ventricular systolic
pressure (RVSP), tissue Doppler imaging was used for the assessment of LV and RV peak velocity (IVV) as well as acceleration
during isovolumic contraction (IVA), peak velocity during ejection phase (S’), peak early diastolic velocity (E’), peak late
diastolic velocity (A’), and ratio of early diastolic mitral/tricuspid velocity to peak early diastolic velocity (E/E’).
Results: Patients who died were significantly older, had lower exercise capacity, more advanced HF, greater impairment of
baseline systolic function, higher baseline pulmonary artery systolic pressure, and most importantly a lack of improvement in
EF, diastolic function, and further increase of RVSP during exercise. Out of all echocardiographic parameters, only peak stress
EF (c2 6.1; p = 0.01), baseline and peak exercise RVSP (c2 12.5 and c2 18.7; p < 0.001; respectively), and mitral E/E’ ratio
(c2 8.9; p < 0.01) were univariate predictors of prognosis and remained independently prognostic when adjusted for age and
sex but were eliminated from the model by NT-proBNP.
Conclusions: During exercise, more severe systolic and diastolic dysfunction with the elevation of pulmonary arterial pres-
sure is more prevalent in HF patients who have a poorer outcome. The estimation of common parameters such as EF, RVSP
and E/E’ using ex-echo, provides prognostic information in HF.
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INTRODUCTION
Despite enormous progress in pharmacotherapy and elec-
trotherapy, the individual outlook for subjects with systolic
heart failure (HF) is still bleak [1]. Prognostic assessment of
patients with overt HF plays a major role in holistic and up-
-to-date approaches to this complex syndrome. A great num-
ber of variables have been associated with poor outcome, of
which a few have been tested and validated using robust pro-
gnostic models [2].
By the nature of HF, gradual impairment of exercise
tolerance is the commonest sign of the disease, and often
the primary reason why patients seek medical attention
[1]. The pathology of poor functional tolerance in HF is
complex and the mechanisms responsible can be briefly
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divided into two types: cardiac (central) and non-cardiac
(peripheral) [3]. Lack of augmentation of left ventricle (LV)
contractility, worsening of LV compliance, increased func-
tional mitral regurgitation or increased pulmonary hyper-
tension are typical cardiac contributors of early termina-
tion of exercise.
However, other mechanisms, such as neuro-hormonal
imbalance, ergo-reflex activation, breathing pattern or adver-
se changes in peripheral muscles have all been shown to af-
fect exercise in HF [4]. There have been numerous theories
put forward to explain the reduction of exercise capacity in
HF; yet still little is known as to whether the aforementioned
cardiac contributors of poor exercise capacity assessed du-
ring exercise carry any independent prognostic information
in HF. Therefore, the main objective of this study was to esta-
blish the prognostic role of cardiac functional parameters as-
sessed during stress, in patients with HF.
METHODS
Study population
This study constitutes an outcome analysis of our project
on exercise echocardiography in systolic HF [5]. Briefly, we
included patients with a confirmed diagnosis of HF based
on the criteria proposed by the European Society of Cardio-
logy, sinus rhythm, no more than trivial mitral and aortic
secondary heart valve disease and an ability to perform an
exercise test on a bicycle [5]. All patients had chronic, sta-
ble, symptomatic HF (NYHA class I to III). Clinical stability
was defined as no hospitalisations, no symptomatic worse-
ning and no change in HF medications for at least three
months prior to the study. Patients with any unstable condi-
tion, including acute coronary syndrome, were excluded
from the trial. The long-term follow-up was obtained via chart
review and telephone contact and was complete for the
85 patients who constituted the study group. The status of
all patients was known and documented up to and inclu-
ding the census date of 1 September 2009. The end-point
of the study was all-cause mortality. The study was appro-
ved by our local Ethics Committee and all participants gave
their written informed consent.
Baseline and stress echocardiography
All echocardiographic examinations were recorded on com-
mercially available equipment (Vivid 7 GE Medical System,
Horten, Norway) with a phased-array 3.5-MHz transducer
and tissue Doppler imaging (TDI) software. For the purpose
of stress echocardiography, we utilised a semi-supine ergo-
meter (Ergoline 9000 Ergoline GmbH, Bitz, Germany) accor-
ding to a protocol previously described (increasing the wor-
kload by 20 watt increments at two minute intervals) [6]. Each
variable represents an average of 3–5 cardiac cycles. Pharma-
cotherapy was continued without change at the time of the
stress tests.
The conventional M-mode, B-mode and Doppler para-
meters were measured according to the current Polish and
American guidelines [7, 8]. Left ventricular ejection fraction
(LVEF) was calculated using a Simpson biplane method of discs
[8]. As a surrogate for pulmonary artery systolic pressure, we
used right ventricular systolic pressure (RVSP) after confirming
the absence of any obstruction to flow between the RV and
pulmonary artery [9, 10]. The RVSP was measured using the
simplified Bernoulli equation.
Tissue Doppler indices were also measured both at rest
and during stress. Real-time colour Doppler myocardial ve-
locities were acquired as data superimposed on an underly-
ing two-dimensional grey-scale image at a frame rate > 150/s
and sector angle of 60 degrees. Both LV and RV were sam-
pled in the apical four-chamber (A4Ch) standard projection,
where a 5 ¥ 5 mm sample volume was positioned at the
lateral border of the tricuspid annulus for RV interrogation,
and at the septal and lateral borders of the mitral annulus
for LV interrogation. The following systolic and diastolic myo-
cardial tissue Doppler signals from LV and RV were measu-
red: peak velocity (IVV) and acceleration during isovolumic
contraction (IVA) and peak velocity during ejection phase
(S’); peak early diastolic velocity (E’); and peak late diastolic
velocity (A’). Additionally, we non-invasively estimated the
filling pressure of LV and RV, as a ratio of early diastolic mi-
tral/tricuspid velocity to peak early diastolic myocardial ve-
locity (sampled from the mitral or tricuspid annulus), na-
mely: E/E’ ratio. The IVA was calculated, as previously de-
scribed by Vogel et al. [11], as a peak velocity during isovo-
lumic contraction divided by the acceleration time, necessary
to achieve peak velocity.
Cardiopulmonary exercise test
Alongside exercise echocardiography, we performed the car-
diopulmonary exercise test using a ZAN Messgeraete GmbH
Ferraris cardiorespiratory instrument (Oberthulba, Germany),
with continuous measurements of peak oxygen uptake
(VO2peak), carbon dioxide production and one-minute ven-
tilation. All study protocols and measurements were in ac-
cordance with the guidelines of the American Thoracic So-
ciety and the American College of Chest Physicians [12].
Statistical analysis
Continuous variables are presented as a mean (standard de-
viation — SD) when normally distributed, or as median (in-
ter-quartile range — IQR) if not, and discrete variables are
presented as frequency counts and percentages. The Kol-
mogorov-Smirnov test was used to verify the normality of
distribution of continuous variables. Comparisons were con-
ducted using the unpaired Student’s t-test for normally di-
stributed variables and the Mann-Whitney U-test for non-
-normally distributed data and c2 test. Cox proportional ha-
zard models were constructed to explore the relationship
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between variables and outcome. If significant, these varia-
bles were then tested in a forward, stepwise multiple Cox
regression survival model to determine independent pre-
dictors of death. Results of these analyses were summarised
as hazard ratios (HR) with 95% confidence intervals (CI) and
associated log-likelihood ratio c2 and p values. Differences
were considered significant when a p value was < 0.05.
The analyses were carried out using STATISTICA software
(StatSoft, Inc., version 6, 2001).
RESULTS
Eighty eight consecutive and eligible HF patients, referred to
our echo laboratory over a period of 12 months, were enrol-
led in the study. Three patients were lost from follow-up, and
therefore are not included in this analysis.
A summary of the characteristics of the 85 patients of
the total study group, and a comparison of the baseline cha-
racteristics of the patients who died (n = 21) with those who
survived (n = 64) is shown in Table 1. The study group was
treated according to contemporary guidelines, with ACE-
-inhibitor and beta-blocker usage at 94% and 92%, respective-
ly. During the follow-up of 43 ± 21 months (IQR 35–49 mo-
nths; minimum 33 and maximum 51 months), 21 (25%) pa-
tients died. Patients who died were significantly older and
had worse HF at baseline, as shown by a higher NYHA class,
N-terminal prohormone of brain natriuretic peptide (NT-
-proBNP) value and worse LV function. Ischaemic heart dise-
ase was more prevalent in non-survivors. Haemoglobin, so-
dium and glomerular filtration rate were higher in the survi-
vors. The use of ACE-I/ARB/spironolacton was similar in both
groups, but patients with favourable outcomes more often
received beta-blockers and less often loop diuretic. Patients
who died during follow-up exercised significantly less and con-
sequently achieved lower peak oxygen uptake.
The comparison of echocardiographic parameters is de-
picted in Table 2. All the participants performed the stress
echo without chest discomfort, significant ST changes, or echo-
cardiographic evidence of inducible ischaemia. The primary
reason for exercise termination was dyspnoea on exertion and
fatigue. As already mentioned, baseline LVEF was significan-
Table 1. Baseline clinical characteristics
Parameters Total cohort (n = 85) Non-survivors (n = 21) Survivos (n = 64) P
Age [years] 62.5 ± 11.8 67.4 ± 10.7 61.3 ± 12.6 0.05
Women/men [%] 19 (22%)/66 (78%) 5 (24%)/16 (76%) 14 (22%)/50 (78%) 0.85
BMI [kg/m2] 28.6 ± 4.9 27.9 ± 4.4 28.9 ± 5.3 0.18
NYHA class 1.94 ± 0.8 2.7 ± 0.47 1.81 ± 0.77 < 0.001
ICM/DCM [%] 53 (62%)/32 (38%) 17 (81%)/4 (19%) 36 (56%)/28 (44%) 0.04
Hypertension [%] 49 (57.6%) 13 (62%) 36 (56%) 0.65
Diabetes mellitus [%] 19 (22%) 5 (24%) 14 (22%) 0.85
Dyslipidemia [%] 52 (61%) 15 (71%) 37 (58%) 0.27
Haemoglobin [g/dL] 13.2 ± 1.8 11.6 ± 1.9 14.3 ± 2.7 < 0.001
GFR [mL/min] 80.3 ± 26.7 73.7 ± 21.6 89.5 ± 19.3 0.005
NT-proBNP [pg/mL] 402.9 ± 206.5 444.6 ± 146.4 251.3 ± 80.7 < 0.001
Sodium [mmol/L] 137.8 ± 11.4 135.3 ± 9.3 139.4 ± 8.5 < 0.001
Beta-blocker [%] 78 (92%) 17 (81%) 61 (95%) 0.05
ACE-I/ARBs [%] 80 (94%) 18 (85%) 62 (97%) 0.06
Loop diuretic [%] 51 (60%) 18 (86%) 33 (52%) 0.006
Spironolacton [%] 68 (80%) 15 (71%) 53 (83%) 0.26
Time of stress [s] 415.9 ± 207.6 311.5 ± 107.8 459.5 ± 228.1 0.02
Load [Watts] 82.6 ± 41.4 57.7 ± 11.1 92.9 ± 52.4  0.04
HR rest [beats/min] 66.3 ± 12.4 69.2 ± 15.7 64.6 ± 13.8 0.21
HR stress [beats/min] 112.7 ± 20.4 102.6 ± 31.4 118.4 ± 27.2 0.14
LBBB [%] 22 (26%) 6 (30%) 14 (22%) 0.5
VO2 peak [mL/kg/min] 15.2 ± 4.9 11.9 ± 2.4 15.6 ± 4.7 0.01
VE/CO2 34.8 ± 7.2 39.3 ± 7.2 30.5 ± 8.7 0.01
BMI — body mass index; NYHA — New York Heart Association; ICM — ischaemic cardiomyopathy; DCM — dilated cardiomyopathy; GFR — glomerular
filtration rate (Cockcroft-Gault equation); NT-proBNP — N-terminal prohormone of brain natriuretic peptide; ACE-I — angiotensin converting enzyme
inhibitor; ARB — angiotensin receptor blocker; HR — heart rate; LBBB — left bundle branch block; VO2 peak — peak oxygen uptake;
VE/CO2 — ventilatory equivalent for carbon dioxide
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tly lower in non-survivors; more importantly, this difference
even widened at peak stress. Patients who died had higher
values of both rest and peak stress RVSP, which may indicate
more prevalent secondary pulmonary hypertension in this
group. Surprisingly, among all TDI indices, only two parame-
ters from LV, both measured during stress, differed significan-
tly between the groups. The high reproducibility of the echo-
cardiographic data has been previously tested and reported
by our study group [5, 13].
Univariate predictors of mortality are shown in Table 3.
The NT-proBNP was the strongest univariate predictor, follo-
wed by VO2peak and age. Of the 12 variables that were signifi-
cant in the univariate analysis, only four remained so in the
multivariable model, and again NT-proBNP remained the
strongest independent predictor of mortality (Table 4). Peak
exercise LVEF and both rest and peak stress RVSP remained
independently prognostic, when adjusted only for age and
sex, but when NT-proBNP was incorporated into the multi-
variable model, all of them lost all statistical significance.
DISCUSSION
Although establishing prognosis on an individual basis may
often be problematic, estimating outcomes in HF is impor-
tant and can be routinely conducted using a wide selection
of prognostic models. Nevertheless, debate still exists as to
how to choose the most informative predictors of prognosis
and the best prognostic model. Furthermore, it is unknown
whether echocardiographic parameters assessed during stress
provide independent and incremental prognostic informa-
tion. Over the last three decades, a sizable number of survi-
val analyses have been performed in a wide selection of HF
patients. Many of the previously powerful models are plainly
out of date since they do not include modern neuro-hormo-
nal pharmacotherapy, nor very strong predictors such as na-
triuretic peptides. Therefore, any up-to-date survival model in
HF should be validated and adjusted for these factors; other-
wise its value may be questionable [14].
In our study, we endeavoured to ascertain whether ad-
ding echocardiographic functional parameters, measured
during stress tests, would improve the predictive power of
survival models in HF. The main findings of our study are
somewhat disappointing, as all analysed cardiac functional
parameters, measured either at rest or peak stress, failed to be
independent predictors of outcome. Only four parameters,
namely baseline and stress RVSP, and LV-E/E’ and LVEF both
at peak stress, were significant in the univariate model but
this significance vanished when adjusted for the NT-proBNP
in the multivariable analysis.
Our study is a helpful contribution to the discussion con-
cerning the role of echocardiographic parameters in the con-
Table 2. Rest and peak stress echocardiographic parameters
Parameters Total cohort (n = 85) Non-survivors (n = 21) Survivos (n = 64) P
LVEDVrest [mL] 177.6 ± 56.4 197 ± 67.7 167.5 ± 72.5 0.08
LVESVrest [mL] 133.6 ± 63.8 143.9 ± 53.2 123.7 ± 61.5 0.05
LVEFrest [%] 27.2 ± 9.5 21.7 ± 7.6 28.3 ± 9.4 0.05
LVEFstress [%] 30.4 ± 13.3 23.4 ± 7.9 33.2 ± 13.4 0.001
LV-IVVrest [cm/s] 3.8 ± 1.6 3.7 ± 1.7 3.8 ± 1.6 0.78
LV-IVVstress [cm/s] 4.6 ± 1.6 4.1 ± 1.3 4.7 ± 1.7 0.17
LV-IVArest [m/s
2] 1.3 ± 0.7 1.1 ± 0.6 1.3 ± 0.7 0.32
LV-IVA stress [m/s
2] 2.1 ± 1.1 1.8 ± 0.8 2.2 ± 1.07 0.37
LV-S’rest [cm/s] 4.6 ± 1.6 4.3 ± 2 4.7 ± 1.6 0.49
LV-S’stress [cm/s] 5.7 ± 1.9 4.9 ± 1.8 5.8 ± 2.1 0.05
LV-E/E’rest 15.2 ± 6.4 16.3 ± 6.5 15 ± 6.4 0.64
LV-E/E’stress 18 ± 6.4 21.4 ± 3.1 17.5 ± 5.6 0.02
RV-S’rest [cm/s] 9.3 ± 3.5 9.2 ± 3.3 9.4 ± 3.4 0.94
RV-S’stress [cm/s] 11.3 ± 4.8 9.5 ± 4.2 11.7 ± 4.8 0.21
RV-E/E’ rest 6.5 ± 3.3 7.6 ± 4.1 6.3 ± 3.1 0.21
RV-E/E’stress 7.1 ± 4.1 7.8 ± 3.2 6.9 ± 4.2 0.45
RVSPrest [mm Hg] 28.2 ± 19.5 45.4 ± 23.9 25.3 ± 17.3 0.003
RVSPstress [mm Hg] 36.3 ± 17.4 56.8 ± 18.6 31.4 ± 21.4 0.001
LVEDV — left ventricular end-diastolic volume; LVESV — left ventricular end-systolic volume; LVEF — left ventricular ejection fraction; LV-S’ — left
ventricular peak velocity during ejection phase; LV-E/E’ — left ventricular ratio of early diastolic mitral velocity to peak early diastolic myocardial velocity;
RVSP — right ventricular systolic pressure; IVV — peak velocity during isovolumic contraction from lateral border of tricuspid annulus; IVA — myocar-
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text of prognosis in HF. There are studies which have repor-
ted that certain echocardiographic variables assessed either
during stress or more commonly at rest are independently
associated with the outcome [15–18]. On the other hand,
some investigations did not support these findings and actu-
ally reported a lack of prognostic significance of echocardio-
graphy [19, 20]. It is difficult to draw robust conclusions from
previous studies, as they greatly differed from each other in
terms of studied population, aetiology of HF, pharmacothe-
rapy, mode of stress test, or the utilisation of natriuretic pep-
tides in survival analysis.
In 1997, Aaronson et al. [2] published their hallmark
study in which they prospectively validated prognostic mo-
dels in 268 HF patients referred for cardiac transplant eva-
luation. This formed a cornerstone for all subsequent survi-
val analysis. One of the strongest predictors was LVEF, along-
side VO2peak and serum sodium. Similarly, we confirmed
VO2peak and serum sodium to be powerful, independent pre-
dictors; but in the case of LVEF, we did not find such a strong
relation with the outcome as in the Heart Failure Survival
Score. It may be that we included a relatively small number
of patients in the analysis. However, the pioneering work of
Aaronson et al. [2] was completed in the pre-beta-blocker
era, which makes any direct comparisons futile, as beta-bloc-
kers greatly affect the outcome in HF. The other issue is that
Aaronson et al. [2] did not incorporate natriuretic peptides
into survival analysis. Natriuretic peptides, particularly BNP,
being the most powerful marker of prognosis in HF, can
lead to the situation that even strong predictors may beco-
me simply too ‘weak’ when directly challenged in the mul-
tivariable analysis.
Studies by Metra et al. [15] and Marmor and Schneewe-
iss [16] have reported that peak exercise stroke work index
determined invasively during stress and contractile reserve re-
spectively, measured non-invasively during dobutamine in-
fusion, were independent predictors of survival. Similarly,
Nagaoka et al. [17] showed that myocardial contractile rese-
rve, measured during exercise radionuclide angiography, can
provide independent information on prognosis in mildly symp-
tomatic patients with DCM. Quantitative assessment of func-
tional mitral regurgitation during exercise also proved valu-
able for the determination of the outcome, as elegantly sho-
wed by Lebrun et al. [18].
However, there have also been some ‘negative’ studies.
Our findings are in agreement with the results of Griffin et al.
[19] who reported a lack of independent prognostic power
Table 3. Univariate predictors of outcome
Parameters c2 P HR 95% CI
NT-proBNP [pg/mL] 117.6 < 0.001 3.5 2.8–3.9
VO2 peak [mL/kg/min] 73.8 < 0.001 1.6 1.3–1.8
Age [years] 71.5 < 0.001 1.1 0.97–1.2
Loop diuretic 31.8 < 0.001 2.3 2–2.6
Sodium [mmol/L] 30.3 < 0.001 0.95 0.93–0.98
Haemoglobin [g/dL] 27.9 < 0.001 0.89 0.84–0.91
NYHA class 21.7 < 0.001 1.5 1.3–1.8
RVSPstress [mm Hg] 18.7 < 0.001 1.3 1.1–1.7
ICM 17.5 < 0.001 1.36 1.09–1.48
RVSPrest [mm Hg] 12.5 < 0.001 0.97 0.95–1
LV-E/E’stress 8.9 < 0.01 1.6 1.3–1.8
LVEFstress [%] 6.1 0.01 1.2 1–1.5
Abbreviations as in Tables 1 and 2
Table 4. Multivariate independent predictors of outcome
Parameters c2 P HR 95% CI
NT-proBNP [pg/mL] 54.8 < 0.001 2.4 1.7–2.9
VO2 peak [mL/kg/min] 32.7 < 0.001 1.4 0.9–1.7
Age [years] 27.6 < 0.001 1.32 1.2–1.52
Sodium [mmol/L] 12.6 0.001 0.96 0.94–1.1
Abbreviations as in Tables 1 and 2
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of common echocardiographic parameters, including LVEF
measured both at rest and during stress in HF. The conclu-
sions of our study are also in line with the trial by Ennezat et
al. [20], who reported that only resting LV end-diastolic volu-
me and tricuspid annular plane systolic excursion were inde-
pendent predictors of death in multivariable analysis, and that
not a single echocardiographic parameter measured during
exercise added any new prognostic information beyond that
already provided by resting measurements.
Pulmonary hypertension is a well-known negative pre-
dictor in HF [21]. The increase of pulmonary artery systolic
pressure during exercise was the strongest echocardiographic
factor in our univariate analysis, which is in line with some
previous trials [21, 22]. Nevertheless, once again, it did not
withstand the predictive power of BNP. Similarly, LV diasto-
lic dysfunction and elevated LV filling pressure are strong
markers of disease severity and important contributors of low
exercise capacity in HF [23]. Lack of improvement of LV fil-
ling during exercise was associated with worse survival, as
determined non-invasively by mitral E/E’ ratio, which dispro-
portionally rose only in patients who died, in contrast to tho-
se with better outcomes.
Probably another important finding of our study is the
fact that we did not observe any advantage of TDI parame-
ters over ‘classical’ echocardiographic indices such as EF or
RVSP in the determination of prognosis. Even novel, less po-
pular indices of isovolumic contraction (IVV and IVA), me-
asured either at rest or peak stress, turned out to be insignifi-
cant in terms of prognosis in our patients. This was clearly not
an anticipated result, as many trials have already confirmed
the value of TDI parameters in different clinical settings. By
way of explanation, it may be that even though TDI parame-
ters such as S’ or E’ are generally perceived as indices of glo-
bal cardiac function, in the context of ischaemic cardiomy-
opathy and regional rather than global functional impairment,
single measurements from a few cardiac sites may not fully
reflect the true impairment. As our study population was too
small to perform a separate survival analysis for dilated or ischa-
emic cardiomyopathy, we cannot say whether TDI indices
would have been of prognostic value in cases of DCM. At this
stage, we can only speculate that if the global systolic func-
tion is severely reduced, as it was in a great number of our
patients, this fact has a more pronounced effect on the out-
come than the impact of the relatively preserved regional
contraction in remote areas of the LV.
Surprisingly, myocardial velocities, measured by means
of TDI, are frequently detected in non-functional (akinetic)
areas of the myocardium because of the tethering effect to
the adjacent tissue. To overcome this potential source of er-
ror and misinterpretation, novel indices of strain rate and strain
have been incorporated. However, the main limitation of
wider usage of those indices is the difficulty in obtaining relia-
ble measurements, especially during stress (low quality of scans
or too high a noise-signal ratio).
In this trial, we included patients with longlasting, stable,
optimally treated HF, who were not considered for myocar-
dial revascularisation, even if they had ischaemic cardiomyo-
pathy, as no inducible ischaemia was detected during stress
test. Therefore our subjects significantly differed from those
individuals with preserved viability, who were subsequently
revascularised, and in some instances, their outcome had been
greatly improved [24, 25].
Limitations of the study
Our study has a number of limitations, which we acknow-
ledge. Undoubtedly, the relatively small number of patients
is a weakness of the study. The other issue concerns the ba-
seline characterisation of the study group, which is at least
10 years younger than a ‘real life’ HF population. Another
limiting factor was the exclusion of patients with severe mitral
regurgitation or atrial fibrillation which may jeopardise direct
comparisons with the general HF population.
CONCLUSIONS
During exercise, more severe systolic and diastolic dysfunc-
tion with elevation of pulmonary arterial pressure is more pre-
valent in HF patients who have a poorer outcome. Exercise
echocardiography, involving the estimation of common pa-
rameters such as EF, RVSP and E/E’ provides some moderate
prognostic information in HF. No advantage for the TDI pa-
rameters over commonly used echocardiographic variables
such as EF or RVSP has been observed in the determination
of prognosis. Larger studies in HF patients are necessary to
determine the real prognostic role of ‘classical’ and novel car-
diac functional parameters.
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Znaczenie prognostyczne echokardiografii
wysiłkowej w niewydolności serca
Paweł Rubiś, Leszek Drabik, Grzegorz Kopeć, Maria Olszowska, Wojciech Płazak, Piotr Podolec
Klinika Chorób Serca i Naczyń, Uniwersytet Jagielloński, Collegium Medicum, Krakowski Szpital Specjalistyczny im. Jana Pawła II, Kraków
S t r e s z c z e n i e
Wstęp i cel: Celem pracy była ocena prognostycznego znaczenia echokardiografii wysiłkowej u chorych z przewlekłą nie-
wydolnością serca (CHF).
Metody: Badaniem objęto 85 kolejnych pacjentów z CHF [66 mężczyzn w wieku 62,5 ± 11,8 (21–83) lat i frakcją wyrzu-
tową lewej komory 27,2 ± 9,5%]. Punktem końcowym była śmiertelność całkowita. W okresie obserwacji trwającej średnio
43 ± 21 miesięcy 21 pacjentów zmarło. Spoczynkowe i wysiłkowe badanie echokardiograficzne, z jednoczesnym pomia-
rem szczytowego zużycia tlenu (VO2peak), wykonano na pół-leżącym ergometrze rowerowym (protokół obciążeń 20 W co
2 min). Oceniono konwencjonalne wskaźniki funkcji skurczowej i rozkurczowej (FW, E/A, DT, IVRT) oraz skurczowe ciśnie-
nie w prawej komorze (RVSP). W lewej i prawej komorze zmierzono także parametry TDI: szczytową prędkość (IVV) i akce-
lerację w czasie skurczu izowolumetrycznego (IVA), szczytową prędkość w fazie wyrzutowej (S’), wczesną (E’) i późną (A’)
prędkość w fazie rozkurczu oraz stosunek fali wczesnego napływu mitralnego/trójdzielnego do wczesno-rozkurczowej pręd-
kości miokardium (E/E’).
Wyniki: Pacjenci, którzy zmarli, byli starsi i stwierdzono u nich niższą wydolność wysiłkową, bardziej zaawansowaną CHF,
bardziej upośledzoną spoczynkową funkcję skurczową lewej komory, wyższe spoczynkowe RVSP, brak poprawy FW i funk-
cji rozkurczowej oraz dalsze narastanie RVSP podczas obciążenia. Spośród wszystkich parametrów echokardiograficznych
jedynie FW na szczycie wysiłku (c2 6,1; p = 0,01), spoczynkowe i wysiłkowe RVSP (c2 12,5 i c2 18,7; p < 0,001; odpowied-
nio) oraz wysiłkowe mitralne E/E’ (c2 8,9; p < 0,01) były istotnymi predyktorami zgonu w jednoczynnikowej analizie Coxa
i pozostały istotne po skorygowaniu względem wieku i płci, natomiast zostały odrzucone w analizie wieloczynnikowej po
wprowadzaniu do modelu NT-proBNP.
Wnioski: Podczas wysiłku większe upośledzenie funkcji skurczowej i rozkurczowej oraz wyższe wartości ciśnienia w tętnicy
płucnej są częstsze u pacjentów z niekorzystnym rokowaniem. Wysiłkowa ocena typowych parametrów echokardiograficz-
nych: FW, RVSP czy E/E’ dostarcza informacji prognostycznych w CHF.
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